PT81347B - Processo para a preparacao de composicoes farmaceuticas que contem glucosidos antraciclinicos - Google Patents

Processo para a preparacao de composicoes farmaceuticas que contem glucosidos antraciclinicos

Info

Publication number
PT81347B
PT81347B PT81347A PT8134785A PT81347B PT 81347 B PT81347 B PT 81347B PT 81347 A PT81347 A PT 81347A PT 8134785 A PT8134785 A PT 8134785A PT 81347 B PT81347 B PT 81347B
Authority
PT
Portugal
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
anthracycline glycosides
containing anthracycline
Prior art date
Application number
PT81347A
Other languages
English (en)
Portuguese (pt)
Other versions
PT81347A (en
Inventor
Gaetano Gatti
Diego Oldani
Carlo Confalonier
Luciano Gambini
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of PT81347A publication Critical patent/PT81347A/pt
Publication of PT81347B publication Critical patent/PT81347B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT81347A 1984-10-22 1985-10-21 Processo para a preparacao de composicoes farmaceuticas que contem glucosidos antraciclinicos PT81347B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848426672A GB8426672D0 (en) 1984-10-22 1984-10-22 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
PT81347A PT81347A (en) 1985-11-01
PT81347B true PT81347B (pt) 1987-11-11

Family

ID=10568553

Family Applications (1)

Application Number Title Priority Date Filing Date
PT81347A PT81347B (pt) 1984-10-22 1985-10-21 Processo para a preparacao de composicoes farmaceuticas que contem glucosidos antraciclinicos

Country Status (35)

Country Link
US (4) US4675311A (en:Method)
JP (1) JPH0611700B2 (en:Method)
KR (1) KR920005813B1 (en:Method)
CN (1) CN85107562B (en:Method)
AT (1) AT401345B (en:Method)
AU (1) AU572003B2 (en:Method)
BE (1) BE903484A (en:Method)
BG (1) BG60934B2 (en:Method)
CA (1) CA1248453A (en:Method)
CH (1) CH667594A5 (en:Method)
CS (1) CS270421B2 (en:Method)
DE (1) DE3536896C2 (en:Method)
DK (1) DK165620C (en:Method)
ES (1) ES8605374A1 (en:Method)
FI (2) FI853913A7 (en:Method)
FR (1) FR2571966B1 (en:Method)
GB (2) GB8426672D0 (en:Method)
GR (1) GR852549B (en:Method)
HK (1) HK94390A (en:Method)
HU (1) HU197988B (en:Method)
IE (1) IE56992B1 (en:Method)
IL (1) IL76732A (en:Method)
IT (1) IT1186779B (en:Method)
MY (1) MY103956A (en:Method)
NL (1) NL191308C (en:Method)
NO (1) NO170616C (en:Method)
NZ (1) NZ213885A (en:Method)
PH (1) PH23982A (en:Method)
PT (1) PT81347B (en:Method)
RU (2) RU1836088C (en:Method)
SE (1) SE467520B (en:Method)
SG (1) SG80290G (en:Method)
UA (2) UA34419C2 (en:Method)
YU (1) YU46160B (en:Method)
ZA (1) ZA858033B (en:Method)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) * 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
KR0158672B1 (en) * 1986-12-05 1998-12-01 Erba Carlo Spa Injectable ready-to-use solutions containing an antitumour anthracycline glycoside
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
US6300361B1 (en) 1990-07-25 2001-10-09 Novartis Ag Stabilized pharmaceutical compositions comprising acid donors
NZ336381A (en) 1996-12-30 2000-11-24 Battelle Memorial Institute Formulation and method for treating neoplasms by inhalation
US5942508A (en) * 1997-02-04 1999-08-24 Senju Pharmaceutical Co., Ltd. Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
RU2292216C2 (ru) * 2000-10-31 2007-01-27 Фарма Мар, С.А. Кахалалид f
DE60321450D1 (de) 2002-02-22 2008-07-17 Schering Corp Pharmazeutische zubereitungen von antineoplastischen wirkstoffen, insbesondere temozolomid, verfahren zu ihrer herstellung und deren verwendung
DK1474995T3 (da) * 2003-05-06 2013-02-18 Gumlink As Fremgangsmåde til fremstilling af tyggegummigranulater, et gummisammensætningsekstruder- og granuleringssystem og et tyggegummiprodukt
US20090099346A1 (en) * 2003-07-02 2009-04-16 Victor Matvienko Thermally stable crystalline epirubicin hydrochloride
ATE520702T1 (de) * 2003-07-02 2011-09-15 Solux Corp Thermisch stabiles kristallines epirubicin- hydrochlorid und herstellungsverfahren dafür
PL2263694T3 (pl) * 2003-09-25 2013-11-29 Astellas Pharma Inc Środek przeciwnowotworowy zawierający FK228 jako inhibitor deacetylazy histonowej i doksorubicynę jako inhibitor topoizomerazy II
RU2262923C2 (ru) * 2003-12-25 2005-10-27 Государственное образовательное учреждение высшего профессионального образования Курский государственный медицинский университет Министерства здравоохранения Российской Федерации Иммобилизованная форма доксорубицина
US7388083B2 (en) * 2005-03-07 2008-06-17 Solux Corporation Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics
WO2006122309A2 (en) * 2005-05-11 2006-11-16 Sicor, Inc. Stable lyophilized anthracycline glycosides
ATE552032T1 (de) 2005-07-14 2012-04-15 Lithera Inc Verbesserte lipolytikum-formulierung mit hinhaltender wirkstofffreigabe für die arealbehandlung von fettgewebe
RU2450013C2 (ru) * 2005-12-13 2012-05-10 Солюкс Корпорейшен Способ получения 4-деметилдаунорубицина
US8802830B2 (en) * 2005-12-20 2014-08-12 Solux Corporation Synthesis of epirubicin from 13-dihydrodaunorubicine
US8148338B2 (en) * 2006-02-22 2012-04-03 Supratek Pharma Inc. Doxorubicin formulations for anti-cancer use
US7470672B2 (en) * 2006-07-31 2008-12-30 Savvipharm Inc. Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
MX2009012370A (es) * 2007-05-16 2010-04-22 Ktb Tumorforschungs Gmbh Formulacion de antraciclina de baja viscosidad.
KR101511398B1 (ko) * 2007-09-04 2015-04-24 메이지 세이카 파루마 가부시키가이샤 주사제, 주사 용액, 및 주사 키트 제제
KR20100058662A (ko) * 2007-10-26 2010-06-03 화이자 프로덕츠 인코포레이티드 개에게서 림프종을 치료하기 위한 이다루비신
US8357785B2 (en) * 2008-01-08 2013-01-22 Solux Corporation Method of aralkylation of 4′-hydroxyl group of anthracylins
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
SG182485A1 (en) * 2010-01-15 2012-08-30 Lithera Inc Lyophilized cake formulations
UA111822C2 (uk) 2010-11-24 2016-06-24 Общєство С Огранічєнной Отвєтствєнностью "Новамедіка" Монотерапевтичий препарат селективного ліпофільного бета-агоніста тривалої дії і спосіб косметичного лікування ожиріння і контурного випинання
DE102011103751A1 (de) 2011-05-31 2012-12-06 Heraeus Precious Metals Gmbh & Co. Kg Kristallisierung von Epirubicinhydrochlorid
DE102011111991A1 (de) * 2011-08-30 2013-02-28 Lead Discovery Center Gmbh Neue Cyclosporin-Derivate
DK2931042T3 (da) 2012-12-13 2021-06-07 Cytrx Corp Anthracyclinformuleringer
AU2014274940B2 (en) 2013-06-05 2019-05-23 Cytrx Corporation Cytotoxic agents for the treatment of cancer

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
US4039663A (en) * 1975-03-19 1977-08-02 Societa' Farmaceutici Italia S.P.A. Daunomycins, process for their uses and intermediates
GB1506200A (en) * 1975-04-30 1978-04-05 Farmaceutici Italia Glycosides
GB1567456A (en) * 1976-11-16 1980-05-14 Farmaceutici Italia Daunomycin derivatives
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
JPS563851A (en) * 1979-06-22 1981-01-16 Matsushita Electric Works Ltd Fireplace in floor
JPS5756494A (en) * 1980-09-22 1982-04-05 Microbial Chem Res Found New anthracyclin derivative
US4325947A (en) * 1981-05-12 1982-04-20 Farmitalia Carlo Erba S.P.A. 4-Demethoxy-4'-deoxydoxorubicin
IT1210476B (it) * 1981-05-28 1989-09-14 Erba Farmitalia Antracicline.
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides
DE3317702A1 (de) * 1982-05-24 1983-11-24 Farmitalia Carlo Erba S.p.A., 20159 Milano Anthracyclinglykoside, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
US4464529A (en) * 1982-07-20 1984-08-07 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
CA1248944A (en) * 1982-09-28 1989-01-17 Gareth J. Thomas Anthracycline glycosides
JPS5982395A (ja) * 1982-11-02 1984-05-12 Microbial Chem Res Found アントラサイクリン化合物、その製造法およびその用途
GR79729B (en:Method) * 1982-12-20 1984-10-31 Univ Ohio State Res Found
JPS6092212A (ja) * 1983-10-26 1985-05-23 Kyowa Hakko Kogyo Co Ltd ドキソルビシン塩の製剤
US4537882A (en) * 1984-05-10 1985-08-27 Ohio State University 4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same

Also Published As

Publication number Publication date
FI86252C (fi) 1992-08-10
CS756585A2 (en) 1989-11-14
GB8525709D0 (en) 1985-11-20
FI853913A7 (fi) 1986-04-23
SE8504945D0 (sv) 1985-10-21
ZA858033B (en) 1986-06-25
DK165620B (da) 1992-12-28
DK481585A (da) 1986-04-23
NO170616B (no) 1992-08-03
IE852593L (en) 1986-04-22
NZ213885A (en) 1988-05-30
NL8502869A (nl) 1986-05-16
AT401345B (de) 1996-08-26
ES8605374A1 (es) 1986-03-16
JPH0611700B2 (ja) 1994-02-16
US4675311A (en) 1987-06-23
PH23982A (en) 1990-02-09
DE3536896A1 (de) 1986-04-24
FI854035A0 (fi) 1985-10-16
FR2571966B1 (fr) 1988-04-15
ES547578A0 (es) 1986-03-16
IL76732A0 (en) 1986-02-28
GB8426672D0 (en) 1984-11-28
SG80290G (en) 1990-11-23
NO170616C (no) 1992-11-11
IT8522507A0 (it) 1985-10-16
US5091373A (en) 1992-02-25
AU4880585A (en) 1986-05-01
MY103956A (en) 1993-10-30
UA34419C2 (uk) 2001-03-15
KR860003014A (ko) 1986-05-19
GB2165751B (en) 1988-08-17
CA1248453A (en) 1989-01-10
NL191308B (nl) 1994-12-16
BE903484A (fr) 1986-04-21
US5091372A (en) 1992-02-25
SE467520B (sv) 1992-08-03
CS270421B2 (en) 1990-06-13
JPS61246129A (ja) 1986-11-01
DK165620C (da) 1993-06-01
ATA303285A (de) 1996-01-15
FI854035L (fi) 1986-04-23
US4840938A (en) 1989-06-20
YU46160B (sh) 1993-05-28
FI86252B (fi) 1992-04-30
IE56992B1 (en) 1992-02-26
RU2101018C1 (ru) 1998-01-10
CN85107562B (zh) 1988-06-01
FR2571966A1 (fr) 1986-04-25
GR852549B (en:Method) 1986-02-24
HUT40759A (en) 1987-02-27
GB2165751A (en) 1986-04-23
UA19169A (uk) 1997-12-25
AU572003B2 (en) 1988-04-28
HU197988B (en) 1989-07-28
RU1836088C (ru) 1993-08-23
BG60934B2 (bg) 1996-06-28
DK481585D0 (da) 1985-10-21
NO854194L (no) 1986-04-23
PT81347A (en) 1985-11-01
DE3536896C2 (de) 1996-11-14
CN85107562A (zh) 1986-07-23
YU164485A (en) 1987-10-31
CH667594A5 (de) 1988-10-31
IL76732A (en) 1989-07-31
FI853913A0 (fi) 1985-10-08
KR920005813B1 (ko) 1992-07-20
IT1186779B (it) 1987-12-16
HK94390A (en) 1990-11-23
SE8504945L (sv) 1986-04-23
NL191308C (nl) 1995-05-16

Similar Documents

Publication Publication Date Title
PT81347B (pt) Processo para a preparacao de composicoes farmaceuticas que contem glucosidos antraciclinicos
PT83013B (pt) Processo para a preparacao de hidroxialquilxantinas terciarias, e de composicoes farmaceuticas que as contem
PT81362B (pt) Processo para a preparacao de 9-amino-1,2,3,4-tetra-hidroacridin-1-ol e compostos relacionados e de composicoes farmaceuticas que os contem
PT80724B (pt) Processo para a preparacao de novos derivados de gangliosidos e de composicoes farmaceuticas que os contem
PT81746B (pt) Processo para a preparacao de peptido-aldeidos e de composicoes farmaceuticas que os contem
PT89094A (pt) Processo para a preparacao de 1-aril-3-quinolina-e 1-aril-3-isoquinolina-carboxamidas e de composicoes farmaceuticas que as contem
PT80892B (pt) Processo para a preparacao de derivados da quoinona e de composicoes farmaceuticas que os contem
PT87880A (pt) Processo para a preparacao de composicoes farmaceuticas anti-virais que contem ciclo-dextrinas
PT83143B (pt) Processo para a preparacao de 1,4-dihidro-piridinas 2-substituidas com tiometilo e de composicoes farmaceuticas que as contem
PT90175A (pt) Processo para preparacao de derivados de gem-difosfonato substituidos por fenol e de composicoes farmaceuticas que os contem
MX9203114A (es) Nuevos derivados morfolino de daunorubicina y doxorubicina y composiciones farmaceuticas que los contienen.
PT81749B (pt) Processo para a preparacao de 1,2,4-triazoles e de composicoes pesticidas que os contem
PT81650B (pt) Processo para a preparacao de novas pteridinas e de composicoes farmaceuticas que as contem
PT89497A (pt) Processo para a preparacao de compostos piperidinilicos 1,4-dissubstituidos e de composicoes farmaceuticas que os contem
ES549299A0 (es) Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.
PT81041B (pt) Processo para a preparacao de derivados de etilenodiamina-monoamida e de composicoes farmaceuticas que os contem
PT80363B (pt) Processo para a preparacao de derivados de fenol e de composicoes farmaceuticas que os contem
PT83397B (pt) Processo para a preparacao de aril-piridinas e de composicoes insecticidas que as contem
PT81636B (pt) Processo para a preparacao de novos benzotiofenos e benzofurados e de composicoes farmaceuticas que os contem
PT93227A (pt) Processo para a preparacao de tetra-hidro-imidazo-{1,4}-benzodiazepin-2-tionas e de composicoes antivirais que as contem
PT84828B (pt) Processo para a preparacao de compostos heterociclicos triciclicos fundidos e de composicoes farmaceuticas que os contem
PT81531B (pt) Processo para a preparacao de silibinina isenta de isosilibina e de composicoes farmaceuticas contendo silibinina
PT84358B (pt) Processo para a preparacao de naftotiazepinonas e de composicoes farmaceuticas que as contem
PT80246B (pt) Processo para a preparacao de novos derivados de cefalosporina e de composicoes farmaceuticas que os contem
PT81659B (pt) Processo para a preparacao de aminoacil-labdanos e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
PC3A Transfer or assignment

Free format text: 961212 PHARMACIA & UPJOHN S.P.A. IT

PC3A Transfer or assignment

Free format text: 20020724 PHARMACIA ITALIA S.P.A. IT

Free format text: PHARMACIA ITALIA S.P.A. IT

Effective date: 20020724